Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
67.65
-0.31 (-0.46%)
Apr 18, 2024, 12:59 PM EDT - Market open
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of $99.43 billion as of April 18, 2024. Its market cap has increased by 36.61% in one year.
Market Cap
99.43B
Enterprise Value
107.86B
1-Year Change
36.61%
Ranking
Category
Stock Price
$67.65
Market Cap Chart
Since December 1, 1998, Boston Scientific's market cap has increased from $10.63B to $99.43B, an increase of 835.17%. That is a compound annual growth rate of 9.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 99.70B | -0.23% |
Apr 16, 2024 | 99.94B | 1.01% |
Apr 15, 2024 | 98.94B | -0.93% |
Apr 12, 2024 | 99.87B | -1.12% |
Apr 11, 2024 | 100.99B | 0.28% |
Apr 10, 2024 | 100.72B | -0.01% |
Apr 9, 2024 | 100.73B | -0.04% |
Apr 8, 2024 | 100.77B | 0.19% |
Apr 5, 2024 | 100.58B | 1.20% |
Apr 4, 2024 | 99.40B | -0.56% |
Apr 3, 2024 | 99.95B | 1.01% |
Apr 2, 2024 | 98.96B | -0.95% |
Apr 1, 2024 | 99.91B | -0.57% |
Mar 28, 2024 | 100.48B | -0.19% |
Mar 27, 2024 | 100.67B | 1.00% |
Mar 26, 2024 | 99.67B | 0.97% |
Mar 25, 2024 | 98.72B | -0.49% |
Mar 22, 2024 | 99.21B | 0.09% |
Mar 21, 2024 | 99.12B | 0.18% |
Mar 20, 2024 | 98.94B | -0.52% |
Mar 19, 2024 | 99.45B | 0.82% |
Mar 18, 2024 | 98.65B | 1.53% |
Mar 15, 2024 | 97.17B | -0.94% |
Mar 14, 2024 | 98.09B | 1.24% |
Mar 13, 2024 | 96.89B | -2.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Stryker | 129.60B |
Elevance Health | 116.88B |
Sanofi | 109.40B |
Medtronic | 107.16B |
Vertex Pharmaceuticals | 103.19B |
Cigna | 99.32B |
Bristol-Myers Squibb Company | 98.94B |
Regeneron Pharmaceuticals | 97.44B |